Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Long-Term Debt RepaymentsShares IssuedShares OutstandingShares Outstanding
Ratios

Tenax Therapeutics (TENX) Receivables - Accured (2016 - 2021)

Tenax Therapeutics' Receivables - Accured history spans 4 years, with the latest figure at $69066.0 for Q4 2017.

  • On a quarterly basis, Receivables - Accured fell 36.53% to $69066.0 in Q4 2017 year-over-year; TTM through Dec 2017 was $69066.0, a 36.53% decrease, with the full-year FY2017 number at $69066.0, down 36.53% from a year prior.
  • Receivables - Accured hit $69066.0 in Q4 2017 for Tenax Therapeutics, down from $71169.0 in the prior quarter.
  • Over the last five years, Receivables - Accured for TENX hit a ceiling of $340376.0 in Q1 2015 and a floor of $69066.0 in Q4 2017.
  • Historically, Receivables - Accured has averaged $194303.6 across 4 years, with a median of $199219.5 in 2016.
  • The widest YoY moves for Receivables - Accured: up 36.53% in 2017, down 63.95% in 2017.
  • Tracing TENX's Receivables - Accured over 4 years: stood at $313848.0 in 2014, then increased by 3.9% to $326074.0 in 2015, then crashed by 66.63% to $108813.0 in 2016, then crashed by 36.53% to $69066.0 in 2017.
  • Business Quant data shows Receivables - Accured for TENX at $69066.0 in Q4 2017, $71169.0 in Q3 2017, and $82994.0 in Q2 2017.